CA4 and neoplasm: Prominent synergistic effects on tumor reduction were observed with RGD-modified liposomes co-encapsulating CA4 and Dox, delineating the importance of a targeted drug delivery system for the co-encapsulation of antiangiogenic and anticancer agents for cancer treatment (Figure 11) [91].